American journal of obstetrics and gynecology
-
Am. J. Obstet. Gynecol. · Sep 2005
Randomized Controlled Trial Comparative Study Clinical TrialHigh-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.
This study was undertaken to compare the efficacy and side effects of a high-dose vaginal misoprostol regimen to concentrated intravenous oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction. ⋯ Compared with concentrated oxytocin plus low-dose vaginal misoprostol, high-dose vaginal misoprostol significantly shortens midtrimester labor inductions.
-
Am. J. Obstet. Gynecol. · Sep 2005
Obstetric outcomes after surgical abortion at > or = 20 weeks' gestation.
The purpose of this study was to describe obstetric outcomes after surgical abortion at > or = 20 weeks, and to identify risk factors for subsequent spontaneous preterm birth. ⋯ In those who have undergone D&E at > or = 20 weeks, only a history of midtrimester cervical dilation and/or PPROM or a current multifetal pregnancy were associated with spontaneous preterm birth.
-
Am. J. Obstet. Gynecol. · Sep 2005
Case ReportsSpontaneous epidural hematoma of the spine in pregnancy.
Spontaneous spinal epidural hematomas are uncommon. Progressive neurologic deficits that are associated with epidural hematomas can develop rapidly and require prompt treatment. We present a case of spontaneous epidural hematoma of the thoracic spine that complicated a term pregnancy.
-
This study was undertaken to determine the incidence and type of resuscitation required for infants delivered by both elective and emergency cesarean section relative to spontaneous vaginal delivery. ⋯ An advanced skills practitioner does not need to be present at elective cesarean sections under regional anesthesia provided there are no additional risk factors.
-
Am. J. Obstet. Gynecol. · Sep 2005
Recombinant human activated protein C treatment of septic shock syndrome in a patient at 18th week of gestation: a case report.
Recombinant human-activated protein C (rhAPC) has been suggested to treat sepsis. We present the case of a 19-year-old pregnant patient at the 18th week of gestation with septic shock syndrome that originated from urinary tract infection and was successfully treated with rhAPC.